Bruce Parker
17 posts
Feb 09, 2024
3:20 AM
|
Buy Mebendazole, a broad-spectrum antiparasitic medication, faced discontinuation due to reports of rare, but severe, adverse effects like agranulocytosis and aplastic anemia. Additionally, newer, more effective alternatives with fewer side effects emerged, leading to a decline in its usage. While it remains available in some regions, regulatory agencies restricted its use, emphasizing careful consideration of risks versus benefits before prescribing.
|
